Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Enbridge (EBGEF) Cash & Equivalents (2016 - 2025)

Enbridge (EBGEF) has disclosed Cash & Equivalents for 16 consecutive years, with $784.5 million as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents fell 39.22% to $784.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $784.5 million through Dec 2025, down 39.22% year-over-year, with the annual reading at $784.5 million for FY2025, 40.43% down from the prior year.
  • Cash & Equivalents for Q4 2025 was $784.5 million at Enbridge, down from $1.0 billion in the prior quarter.
  • The five-year high for Cash & Equivalents was $4.3 billion in Q4 2023, with the low at $226.9 million in Q4 2021.
  • Average Cash & Equivalents over 5 years is $1.1 billion, with a median of $802.1 million recorded in 2022.
  • The sharpest move saw Cash & Equivalents skyrocketed 583.35% in 2023, then tumbled 70.22% in 2024.
  • Over 5 years, Cash & Equivalents stood at $226.9 million in 2021, then skyrocketed by 179.56% to $634.3 million in 2022, then surged by 583.35% to $4.3 billion in 2023, then plummeted by 70.22% to $1.3 billion in 2024, then tumbled by 39.22% to $784.5 million in 2025.
  • According to Business Quant data, Cash & Equivalents over the past three periods came in at $784.5 million, $1.0 billion, and $868.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.